Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $13.11 $15.83 Friday, 10th May 2024 SRRK stock ended at $13.35. This is 8.25% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 8.97% from a day low at $13.19 to a day high of $14.37.
90 days $12.81 $17.90
52 weeks $5.56 $21.17

Historical Scholar Rock Holding Corp. prices

Date Open High Low Close Volume
Nov 09, 2023 $11.89 $12.05 $10.07 $10.21 824 501
Nov 08, 2023 $12.40 $12.63 $11.82 $11.95 547 443
Nov 07, 2023 $11.70 $12.75 $11.46 $12.35 707 321
Nov 06, 2023 $12.40 $12.64 $12.02 $12.17 597 016
Nov 03, 2023 $12.75 $13.15 $12.38 $12.41 552 051
Nov 02, 2023 $12.30 $12.58 $12.14 $12.54 652 138
Nov 01, 2023 $11.84 $12.42 $11.41 $12.30 705 640
Oct 31, 2023 $11.55 $11.88 $10.75 $11.76 865 506
Oct 30, 2023 $10.34 $11.89 $10.14 $11.53 1 395 941
Oct 27, 2023 $10.61 $11.24 $10.15 $10.34 1 187 687
Oct 26, 2023 $9.00 $10.79 $9.00 $10.61 1 997 236
Oct 25, 2023 $8.46 $9.31 $8.35 $9.02 2 059 165
Oct 24, 2023 $7.48 $7.78 $7.28 $7.66 705 293
Oct 23, 2023 $7.65 $7.78 $7.37 $7.53 1 604 655
Oct 20, 2023 $7.51 $8.05 $7.50 $7.64 584 661
Oct 19, 2023 $7.87 $7.98 $6.50 $7.50 2 727 055
Oct 18, 2023 $8.58 $8.77 $7.45 $7.52 918 941
Oct 17, 2023 $8.72 $8.78 $8.10 $8.70 878 933
Oct 16, 2023 $7.80 $8.46 $7.77 $8.26 1 026 013
Oct 13, 2023 $8.19 $8.19 $7.17 $7.84 1 011 249
Oct 12, 2023 $7.73 $9.24 $7.56 $8.06 4 491 421
Oct 11, 2023 $7.16 $7.35 $6.60 $6.85 224 613
Oct 10, 2023 $7.20 $7.26 $6.87 $7.13 333 369
Oct 09, 2023 $7.25 $7.52 $7.01 $7.22 267 726
Oct 06, 2023 $7.31 $8.58 $7.26 $7.37 554 489
Click to get the best stock tips daily for free!

About Scholar Rock Holding Corp.

Scholar Rock Holding . Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical tria... SRRK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT